| Name | Market Cap | Current Price | P/E Ratio | Revenue Growth 1Y | Net Margin | ROE | FCF Yield | Debt/Equity |
|---|---|---|---|---|---|---|---|---|
| KRYSKrystal Biotech, Inc. | 8.47B | 291.93 | 97.31 | 473.02% | 53.3% | 17.48% | 1.41% | 0.01 |
| BMRNBioMarin Pharmaceutical Inc. | 10.6B | 55.20 | 24.98 | 17.97% | 16.82% | 8.59% | 4.48% | 0.11 |
| SRPTSarepta Therapeutics, Inc. | 2.25B | 21.46 | 9.17 | 52.97% | -11.25% | -20.57% | 0.88 | |
| RAREUltragenyx Pharmaceutical Inc. | 2.33B | 24.11 | -3.83 | 29.01% | -91.95% | -35.88% | 0.15 | |
| DYNDyne Therapeutics, Inc. | 2.81B | 17.04 | -5.06 | -61.26% | 0.04 | |||
| TVTXTravere Therapeutics, Inc. | 2.6B | 29.11 | -7.13 | 60.55% | -20.32% | -120.36% | 6.80 | |
| BEAMBeam Therapeutics Inc. | 3.51B | 34.55 | -7.54 | -83.18% | -7.44% | -42.92% | 0.22 | |
| SLNOSoleno Therapeutics, Inc. | 2.23B | 41.51 | -9.48 | -79.5% | -15.85% | 0.22 |
| Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales/Revenue | 10.3M | 25.1M | 13.11M | 11.28M | 7.28M | 37.51M | 524M | 106.48M | 15.84M | 27.12M |
| Revenue Growth % | 0.81% | 1.44% | -0.48% | -0.14% | -0.35% | 4.15% | 12.97% | -0.8% | -0.85% | 0.71% |
| Cost of Goods Sold | 638.49K | 72.69M | 67.41M | 73.06M | 0 | 122.4M | 24.98M | 3.34M | 13.63M | 18.33M |
| COGS % of Revenue | 0.06% | 2.9% | 5.14% | 6.47% | - | 3.26% | 0.05% | 0.03% | 0.86% | 0.68% |
| Gross Profit | 9.67M | -47.59M | -54.3M | -61.78M | 7.28M | -84.89M | 499.03M | 103.14M | 2.21M | 8.79M |
| Gross Margin % | 0.94% | -1.9% | -4.14% | -5.47% | 1% | -2.26% | 0.95% | 0.97% | 0.14% | 0.32% |
| Gross Profit Growth % | 1.26% | -5.92% | -0.14% | -0.14% | 1.12% | -12.66% | 6.88% | -0.79% | -0.98% | 2.97% |
| Operating Expenses | 71.76M | 97.04M | 85.06M | 99.52M | 128.42M | 40.54M | 188.41M | 246.3M | 285.09M | 193.09M |
| OpEx % of Revenue | 6.96% | 3.87% | 6.49% | 8.82% | 17.64% | 1.08% | 0.36% | 2.31% | 17.99% | 7.12% |
| Selling, General & Admin | 21.12M | 26M | 25.04M | 25.3M | 33.54M | 42.58M | 56.29M | 54.7M | 73.08M | 50.68M |
| SG&A % of Revenue | 2.05% | 1.04% | 1.91% | 2.24% | 4.61% | 1.14% | 0.11% | 0.51% | 4.61% | 1.87% |
| Research & Development | 51.15M | 72.51M | 72.38M | 74.81M | 94.74M | 122.4M | 143.55M | 197.59M | 214.86M | 143.78M |
| R&D % of Revenue | 4.96% | 2.89% | 5.52% | 6.63% | 13.01% | 3.26% | 0.27% | 1.86% | 13.56% | 5.3% |
| Other Operating Expenses | 0 | -283K | 600K | -598K | 140K | -124.44M | -11.43M | -5.99M | -2.86M | -1.38M |
| Operating Income | -74.82M | -71.95M | -71.96M | -88.23M | -121.14M | -125.43M | 310.62M | -143.16M | -282.87M | -184.29M |
| Operating Margin % | -7.26% | -2.87% | -5.49% | -7.82% | -16.64% | -3.34% | 0.59% | -1.34% | -17.85% | -6.8% |
| Operating Income Growth % | -0.82% | 0.04% | -0% | -0.23% | -0.37% | -0.04% | 3.48% | -1.46% | -0.98% | 0.35% |
| EBITDA | -69.97M | -65.86M | -64.41M | -81.33M | -114.47M | -114.78M | 317.92M | -134.62M | -270.97M | -171.65M |
| EBITDA Margin % | -6.79% | -2.62% | -4.91% | -7.21% | -15.72% | -3.06% | 0.61% | -1.26% | -17.1% | -6.33% |
| EBITDA Growth % | -0.78% | 0.06% | 0.02% | -0.26% | -0.41% | -0% | 3.77% | -1.42% | -1.01% | 0.37% |
| D&A (Non-Cash Add-back) | 4.86M | 6.09M | 7.54M | 6.9M | 6.67M | 10.65M | 7.3M | 8.54M | 11.9M | 12.64M |
| EBIT | -80.69M | -70.06M | -77.23M | -80.91M | -120.39M | -137.62M | 311.7M | -116.56M | -265M | -173.39M |
| Net Interest Income | -2.45M | -2.1M | -2.36M | 569K | -263K | -2.89M | -7.31M | -11.1M | -22M | -42.33M |
| Interest Income | 121K | 70K | 117K | 2.73M | 3.55M | 938K | 162K | 609K | 19.56M | 21.41M |
| Interest Expense | 2.57M | 2.17M | 2.48M | 2.16M | 3.81M | 3.83M | 7.47M | 11.7M | 41.56M | 63.74M |
| Other Income/Expense | -12.11M | -283K | -8.12M | 5.16M | -3.06M | -16.02M | 22.19M | 14.9M | -23.69M | -52.83M |
| Pretax Income | -78.62M | -72.23M | -80.59M | -83.07M | -124.2M | -141.44M | 332.81M | -128.26M | -306.56M | -237.13M |
| Pretax Margin % | -7.63% | -2.88% | -6.15% | -7.36% | -17.06% | -3.77% | 0.64% | -1.2% | -19.35% | -8.74% |
| Income Tax | 471.21K | 1.15M | -199K | 231K | 0 | -16.42M | 3.22M | -1.47M | 1.92M | 2.43M |
| Effective Tax Rate % | 0.99% | 1.02% | 1% | 1% | 1% | 0.88% | 0.99% | 0.99% | 1.01% | 1.01% |
| Net Income | -78.15M | -73.37M | -80.39M | -83.3M | -124.2M | -125.02M | 329.59M | -126.79M | -308.48M | -239.56M |
| Net Margin % | -7.58% | -2.92% | -6.13% | -7.38% | -17.06% | -3.33% | 0.63% | -1.19% | -19.47% | -8.83% |
| Net Income Growth % | -0.74% | 0.06% | -0.1% | -0.04% | -0.49% | -0.01% | 3.64% | -1.38% | -1.43% | 0.22% |
| Net Income (Continuing) | -79.27M | -73.37M | -79.26M | -83.3M | -124.2M | -125.02M | 329.59M | -126.79M | -308.48M | -239.56M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -3.54 | -2.93 | -2.98 | -2.34 | -3.20 | -2.81 | 7.04 | -2.71 | -6.47 | -4.92 |
| EPS Growth % | -0.35% | 0.17% | -0.02% | 0.21% | -0.37% | 0.12% | 3.51% | -1.38% | -1.39% | 0.24% |
| EPS (Basic) | -3.54 | -2.93 | -2.98 | -2.34 | -3.20 | -2.81 | 7.17 | -2.71 | -6.47 | -4.92 |
| Diluted Shares Outstanding | 22.06M | 25.04M | 26.98M | 35.64M | 40M | 44.47M | 46.84M | 46.74M | 47.67M | 48.65M |
| Basic Shares Outstanding | 22.06M | 25.04M | 26.98M | 35.64M | 40M | 44.47M | 45.99M | 46.74M | 47.67M | 48.65M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - |
| Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Current Assets | 229.03M | 143.95M | 162.78M | 236.58M | 384.21M | 258.91M | 628.24M | 476.77M | 651.85M | 390.29M |
| Cash & Short-Term Investments | 222.52M | 132.5M | 159.37M | 234.9M | 377.79M | 244.93M | 556.26M | 352.84M | 617.89M | 367.52M |
| Cash Only | 222.52M | 132.5M | 159.37M | 234.9M | 377.79M | 244.93M | 556.26M | 228.01M | 241.36M | 158.93M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 124.83M | 376.53M | 208.59M |
| Accounts Receivable | 4.13M | 9.18M | 1.59M | 233K | 947K | 6.62M | 58.77M | 102.38M | 4.19M | 5.88M |
| Days Sales Outstanding | 146.26 | 133.5 | 44.17 | 7.54 | 47.47 | 64.39 | 40.94 | 350.92 | 96.6 | 79.15 |
| Inventory | 475.59K | 996K | 1.14M | 1.12M | 0 | 0 | 0 | 6.92M | 12.02M | 0 |
| Days Inventory Outstanding | 271.87 | 5 | 6.17 | 5.58 | - | - | - | 755.99 | 322.04 | - |
| Other Current Assets | 1.19M | 1.27M | 687K | 329K | -3.97M | 3.02M | 2.67M | 2.81M | 2.65M | 7.61M |
| Total Non-Current Assets | 35.66M | 46.32M | 46.09M | 37.33M | 64.42M | 81.48M | 180.94M | 228.19M | 179.84M | 166.25M |
| Property, Plant & Equipment | 26.04M | 35.7M | 34.28M | 29.18M | 55.57M | 58.41M | 69.08M | 83.26M | 75.34M | 34.07M |
| Fixed Asset Turnover | 0.40x | 0.70x | 0.38x | 0.39x | 0.13x | 0.64x | 7.59x | 1.28x | 0.21x | 0.80x |
| Goodwill | 483.24K | 465K | 530K | 506K | 496K | 542K | 27.63M | 25.58M | 26.38M | 22.41M |
| Intangible Assets | 7.88M | 8.32M | 8.8M | 5.2M | 5.43M | 3.36M | 62.69M | 58.78M | 60.48M | 71.04M |
| Long-Term Investments | 1.24M | 1.83M | 2.48M | 2.44M | 2.93M | 2.75M | 0 | 39.98M | 2.18M | 27.46M |
| Other Non-Current Assets | 1.25M | 1.83M | 2.48M | 2.44M | 2.93M | 0 | 5.9M | 6.06M | 3.18M | 1.4M |
| Total Assets | 264.69M | 190.26M | 208.88M | 273.91M | 448.63M | 340.39M | 809.18M | 704.96M | 831.69M | 556.54M |
| Asset Turnover | 0.04x | 0.13x | 0.06x | 0.04x | 0.02x | 0.11x | 0.65x | 0.15x | 0.02x | 0.05x |
| Asset Growth % | 1.27% | -0.28% | 0.1% | 0.31% | 0.64% | -0.24% | 1.38% | -0.13% | 0.18% | -0.33% |
| Total Current Liabilities | 26.65M | 22.72M | 19.29M | 19.97M | 31.63M | 27.33M | 36.76M | 75.92M | 73.67M | 40.05M |
| Accounts Payable | 4.06M | 5.52M | 2.91M | 3.79M | 5.68M | 3.77M | 2.5M | 10.98M | 6.59M | 7.23M |
| Days Payables Outstanding | 2.32K | 27.74 | 15.75 | 18.94 | - | 11.25 | 36.56 | 1.2K | 176.39 | 143.93 |
| Short-Term Debt | 5.58M | 605K | 1.05M | 0 | 0 | 5.52M | 5.77M | 8.38M | 0 | 0 |
| Deferred Revenue (Current) | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 0 | 0 |
| Other Current Liabilities | 10.3M | 1.07M | 2.67M | 856K | 0 | 8.27M | 2.87M | 28.23M | 45.91M | 19.12M |
| Current Ratio | 8.59x | 6.34x | 8.44x | 11.85x | 12.15x | 9.47x | 17.09x | 6.28x | 8.85x | 9.74x |
| Quick Ratio | 8.58x | 6.29x | 8.38x | 11.79x | 12.15x | 9.47x | 17.09x | 6.19x | 8.68x | 9.74x |
| Cash Conversion Cycle | -1.9K | 110.77 | 34.59 | -5.83 | - | - | - | -92.36 | 242.25 | - |
| Total Non-Current Liabilities | 107.41M | 103.91M | 99.64M | 74.33M | 93.94M | 69.16M | 176.64M | 153.04M | 550.34M | 523.24M |
| Long-Term Debt | 14.63M | 19.63M | 19.74M | 35.47M | 36.06M | 35.62M | 100.96M | 102.79M | 101.75M | 51.32M |
| Capital Lease Obligations | 0 | 0 | 0 | 0 | 31.13M | 30.4M | 28.99M | 31.72M | 28.32M | 11.14M |
| Deferred Tax Liabilities | 6.85M | 6.78M | 10.41M | 9.56M | 0 | 0 | 12.91M | 8.26M | 7.54M | 7.04M |
| Other Non-Current Liabilities | 85.92M | 8.67M | 13.91M | 10M | 3.61M | 3.14M | 33.78M | 10.27M | 412.74M | 453.73M |
| Total Liabilities | 134.06M | 126.63M | 118.93M | 94.3M | 125.57M | 96.49M | 213.4M | 228.96M | 624.02M | 563.29M |
| Total Debt | 21.18M | 20.24M | 20.18M | 35.47M | 73.06M | 71.54M | 135.72M | 142.89M | 138.41M | 66.06M |
| Net Debt | -201.34M | -112.26M | -139.2M | -199.43M | -304.73M | -173.39M | -420.53M | -85.12M | -102.95M | -92.87M |
| Debt / Equity | 0.16x | 0.32x | 0.22x | 0.20x | 0.23x | 0.29x | 0.23x | 0.30x | 0.67x | - |
| Debt / EBITDA | - | - | - | - | - | - | 0.43x | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | -1.32x | - | - | - |
| Interest Coverage | -29.09x | -33.12x | -29.07x | -40.85x | -31.80x | -32.79x | 41.56x | -12.23x | -6.81x | -2.89x |
| Total Equity | 130.63M | 63.63M | 89.94M | 179.61M | 323.06M | 243.91M | 595.78M | 476.01M | 207.67M | -6.75M |
| Equity Growth % | 1.49% | -0.51% | 0.41% | 1% | 0.8% | -0.25% | 1.44% | -0.2% | -0.56% | -1.03% |
| Book Value per Share | 5.92 | 2.54 | 3.33 | 5.04 | 8.08 | 5.49 | 12.72 | 10.19 | 4.36 | -0.14 |
| Total Shareholders' Equity | 130.63M | 63.63M | 89.94M | 179.61M | 323.06M | 243.91M | 595.78M | 476.01M | 207.67M | -6.75M |
| Common Stock | 1.33M | 1.59M | 1.95M | 2.3M | 2.65M | 2.71M | 2.8M | 2.84M | 2.88M | 2.94M |
| Retained Earnings | -276.13M | -396.06M | -467.12M | -535.51M | -659.71M | -784.73M | -455.14M | -581.93M | -890.41M | -1.13B |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 28.45M | -6.56M | 39.08M | -7.26M | -6.69M | 9.91M | -28.86M | -58.29M | -53.55M | -52.8M |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations | 18.78M | -72.19M | -64.27M | -76.04M | -98.68M | -134.83M | 287.96M | -145.06M | -145.93M | -182.73M |
| Operating CF Margin % | 1.82% | -2.88% | -4.9% | -6.74% | -13.55% | -3.59% | 0.55% | -1.36% | -9.21% | -6.74% |
| Operating CF Growth % | 1.61% | -4.84% | 0.11% | -0.18% | -0.3% | -0.37% | 3.14% | -1.5% | -0.01% | -0.25% |
| Net Income | -78.15M | -73.37M | -80.39M | -83.3M | -124.2M | -125.02M | 329.59M | -126.79M | -308.48M | -239.56M |
| Depreciation & Amortization | 4.86M | 6.09M | 8.31M | 12.41M | 6.67M | 10.65M | 7.3M | 8.54M | 11.9M | 12.64M |
| Stock-Based Compensation | 8.34M | 6.21M | 10.13M | 10.71M | 17.53M | 21.83M | 25.64M | 34.2M | 35.09M | 22.26M |
| Deferred Taxes | -523.69K | 1.15M | 209K | 231K | 0 | -16.42M | 3.21M | -1.47M | 1.92M | 2.43M |
| Other Non-Cash Items | 16.06M | -1.97M | 10.12M | -9.89M | 3.42M | -19.39M | -27.29M | -16.16M | 32.51M | 23.44M |
| Working Capital Changes | 68.19M | -10.29M | -12.65M | -6.2M | -2.11M | -6.47M | -50.48M | -43.38M | 81.12M | -3.94M |
| Change in Receivables | -1.72M | -5.42M | 9.71M | 1.58M | -4.77M | -6.97M | -58.96M | -49.08M | -1.32M | -2.24M |
| Change in Inventory | -256.93K | 480K | 382K | -382K | 4.77M | 0 | 0 | -6.92M | -6.74M | 2.42M |
| Change in Payables | 0 | 344K | -1.67M | 1.06M | 1.65M | -2.7M | -727K | 9.24M | -4.17M | 1.52M |
| Cash from Investing | -9.31M | -17.79M | -6.15M | -4.25M | -6.65M | -9.48M | -67.39M | -182.73M | -205.69M | 162.97M |
| Capital Expenditures | -9.41M | -17.17M | -5.58M | -4.25M | -6.65M | -7.27M | -17.44M | -17.69M | -7.15M | -11.69M |
| CapEx % of Revenue | 0.91% | 0.68% | 0.43% | 0.38% | 0.91% | 0.19% | 0.03% | 0.17% | 0.45% | 0.43% |
| Acquisitions | - | - | - | - | - | - | - | - | - | - |
| Investments | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 99.49K | -613K | -567K | -1.86M | 0 | -2.21M | 0 | 0 | 0 | 0 |
| Cash from Financing | 150.4M | 2.44M | 90.07M | 157.96M | 248.82M | 7.44M | 94.86M | 1.45M | 362.72M | -59.49M |
| Debt Issued (Net) | - | - | - | - | - | - | - | - | - | - |
| Equity Issued (Net) | - | - | - | - | - | - | - | - | - | - |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | - | - | - | - | - | - | - | - | - | - |
| Other Financing | 2.87M | 2.59M | 4.78M | 4.83M | 6.1M | 0 | -1.33M | 0 | -7.65M | -8.56M |
| Net Change in Cash | - | - | - | - | - | - | - | - | - | - |
| Free Cash Flow | 9.36M | -89.36M | -69.85M | -80.28M | -105.33M | -144.31M | 270.52M | -162.75M | -153.08M | -186.1M |
| FCF Margin % | 0.91% | -3.56% | -5.33% | -7.11% | -14.47% | -3.85% | 0.52% | -1.53% | -9.66% | -6.86% |
| FCF Growth % | 1.17% | -10.55% | 0.22% | -0.15% | -0.31% | -0.37% | 2.87% | -1.6% | 0.06% | -0.22% |
| FCF per Share | 0.42 | -3.57 | -2.59 | -2.25 | -2.63 | -3.25 | 5.78 | -3.48 | -3.21 | -3.83 |
| FCF Conversion (FCF/Net Income) | -0.24x | 0.98x | 0.80x | 0.91x | 0.79x | 1.08x | 0.87x | 1.14x | 0.47x | 0.76x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 4.13M | 6.54M | 9.25M | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Metric | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | -85.4% | -75.54% | -104.69% | -61.81% | -49.42% | -44.1% | 78.5% | -23.66% | -90.24% | -238.46% |
| Return on Invested Capital (ROIC) | - | - | - | - | - | -211.77% | 189.59% | -37.93% | -85.61% | -5422.54% |
| Gross Margin | 93.8% | -189.62% | -414.3% | -547.47% | 100% | -226.28% | 95.23% | 96.86% | 13.98% | 32.42% |
| Net Margin | -758.41% | -292.35% | -613.33% | -738.25% | -1705.82% | -333.27% | 62.9% | -119.07% | -1947.09% | -883.35% |
| Debt / Equity | 0.16x | 0.32x | 0.22x | 0.20x | 0.23x | 0.29x | 0.23x | 0.30x | 0.67x | - |
| Interest Coverage | -29.09x | -33.12x | -29.07x | -40.85x | -31.80x | -32.79x | 41.56x | -12.23x | -6.81x | -2.89x |
| FCF Conversion | -0.24x | 0.98x | 0.80x | 0.91x | 0.79x | 1.08x | 0.87x | 1.14x | 0.47x | 0.76x |
| Revenue Growth | 80.87% | 143.57% | -47.78% | -13.91% | -35.48% | 415.23% | 1296.82% | -79.68% | -85.12% | 71.17% |
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|
| Collaboration revenues | - | - | - | 6.6M | 4.77M | 2.25M | 10.87M |
| Collaboration revenues Growth | - | - | - | - | -27.81% | -52.79% | 383.20% |
| License revenues | - | - | - | 517.4M | 100M | 2.76M | 10.13M |
| License revenues Growth | - | - | - | - | -80.67% | -97.24% | 267.40% |
| License revenues from related party | - | - | - | - | - | - | - |
| License revenues from related party Growth | - | - | - | - | - | - | - |
| License Revenue From Related Party | 7.53M | 4.99M | 32.97M | - | - | - | - |
| License Revenue From Related Party Growth | - | -33.74% | 560.93% | - | - | - | - |
| License | - | - | 4.35M | - | - | - | - |
| License Growth | - | - | - | - | - | - | - |
| Collaborative Revenue From Related Party | 3.76M | 2.29M | 136K | - | - | - | - |
| Collaborative Revenue From Related Party Growth | - | -38.95% | -94.07% | - | - | - | - |
| Collaborative Revenue | - | - | 59K | - | - | - | - |
| Collaborative Revenue Growth | - | - | - | - | - | - | - |
uniQure N.V. (QURE) reported $15.8M in revenue for fiscal year 2024.
uniQure N.V. (QURE) grew revenue by 71.2% over the past year. This is strong growth.
uniQure N.V. (QURE) reported a net loss of $235.1M for fiscal year 2024.
uniQure N.V. (QURE) has a return on equity (ROE) of -238.5%. Negative ROE indicates the company is unprofitable.
uniQure N.V. (QURE) had negative free cash flow of $153.6M in fiscal year 2024, likely due to heavy capital investments.